NUR 209 Lecture Notes - Lecture 24: Peripheral Artery Disease, Pulmonary Artery, Pleurisy
Document Summary
Clinical manifestations: depend on the size of the thrombus and the area affected, dyspnea, chest pain (sudden, pleuritic, anxiety, apprehension, fever, tachycardia, syncope, cough, hemoptysis, diaphoresis. Assessment and diagnostics: early recognition and diagnosis is priority, assess clinical probability of risk, history, s&s, cxr. 9/2/20: cxr, ecg, pulse oximetry, abg, v/q scan or pulmonary angiogram/mdcta. Risk factors for pulmonary emboli: immobility, venous stasis, hypercoagulability, heart disease, trauma, postoperative/postpartum, diabetes, copd, obesity, oral contraceptive use, previous history of thrombophlebitis. 1: causes lysis of the dvt, pe, dissolves the clot, patients who do not have contraindication or potential bleeding risk, tpa. 2: prevents formation of the clot, vte prophylaxis, can be long term therapy, antiplatelet therapy, interfere with platelet function, prevent/treat cv disease. 1: aspirin, clopidogrel (plavix, prasugrel (effient, glycoprotien iib/iiia agents, abciximab (reopro, eptifibatide (intergrilin, anticoagulant medication. 2: heparin, lmwh, enoxaparin (lovenox, dalteparin (fragmin, warfarin (coumadin)
